6523 Stock Overview
Dr. Wu Skincare Co., Ltd. develops and sells skincare and cosmetics products in Taiwan and internationally.
Dr. Wu Skincare Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$81.60|
|52 Week High||NT$152.50|
|52 Week Low||NT$69.40|
|1 Month Change||2.00%|
|3 Month Change||2.13%|
|1 Year Change||11.63%|
|3 Year Change||32.47%|
|5 Year Change||-37.23%|
|Change since IPO||-55.49%|
Recent News & Updates
|6523||TW Personal Products||TW Market|
Return vs Industry: 6523 exceeded the TW Personal Products industry which returned -17.6% over the past year.
Return vs Market: 6523 exceeded the TW Market which returned -13.2% over the past year.
|6523 Average Weekly Movement||4.2%|
|Personal Products Industry Average Movement||4.6%|
|Market Average Movement||5.1%|
|10% most volatile stocks in TW Market||8.4%|
|10% least volatile stocks in TW Market||2.5%|
Stable Share Price: 6523 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 6523's weekly volatility (4%) has been stable over the past year.
About the Company
Dr. Wu Skincare Co., Ltd. develops and sells skincare and cosmetics products in Taiwan and internationally. The company offers cleansers, masks, toners, serums, lotion/cream/gel, UV/DD creams, and eye care products, as well as makeup and body products. It also provides products for acne and pores, blackheads, dry skin, signs of aging, dull and spotty skin, sensitive skin, whitening, and emergency care.
Dr. Wu Skincare Fundamentals Summary
|6523 fundamental statistics|
Is 6523 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|6523 income statement (TTM)|
|Cost of Revenue||NT$415.45m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||7.16|
|Net Profit Margin||28.65%|
How did 6523 perform over the long term?See historical performance and comparison
13.7%Current Dividend Yield
Is 6523 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 4/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 6523?
Other financial metrics that can be useful for relative valuation.
|What is 6523's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 6523's PE Ratio compare to its peers?
|6523 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
4190 Jourdeness Group
1783 Maxigen Biotech
8480 Taisun Int'l (Holding)
6523 Dr. Wu Skincare
Price-To-Earnings vs Peers: 6523 is good value based on its Price-To-Earnings Ratio (11.4x) compared to the peer average (19x).
Price to Earnings Ratio vs Industry
How does 6523's PE Ratio compare vs other companies in the Asian Personal Products Industry?
Price-To-Earnings vs Industry: 6523 is good value based on its Price-To-Earnings Ratio (11.4x) compared to the TW Personal Products industry average (19.2x)
Price to Earnings Ratio vs Fair Ratio
What is 6523's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||11.4x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 6523's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 6523 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 6523 (NT$81.6) is trading below our estimate of fair value (NT$141.06)
Significantly Below Fair Value: 6523 is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Dr. Wu Skincare forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dr. Wu Skincare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Examine whether Dr. Wu Skincare is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
How has Dr. Wu Skincare performed over the past 5 years?
Past Performance Score3/6
Past Performance Score 3/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 6523 has high quality earnings.
Growing Profit Margin: 6523's current net profit margins (28.6%) are lower than last year (84.9%).
Past Earnings Growth Analysis
Earnings Trend: 6523's earnings have grown significantly by 32.8% per year over the past 5 years.
Accelerating Growth: 6523's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 6523 had negative earnings growth (-53.6%) over the past year, making it difficult to compare to the Personal Products industry average (-29.7%).
Return on Equity
High ROE: 6523's Return on Equity (20.8%) is considered high.
Discover strong past performing companies
How is Dr. Wu Skincare's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 6523's short term assets (NT$1.7B) exceed its short term liabilities (NT$302.2M).
Long Term Liabilities: 6523's short term assets (NT$1.7B) exceed its long term liabilities (NT$15.9M).
Debt to Equity History and Analysis
Debt Level: 6523 is debt free.
Reducing Debt: 6523 had no debt 5 years ago.
Debt Coverage: 6523 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 6523 has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies
What is Dr. Wu Skincare current dividend yield, its reliability and sustainability?
Dividend Score 2/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 6523's dividend (13.75%) is higher than the bottom 25% of dividend payers in the TW market (2.53%).
High Dividend: 6523's dividend (13.75%) is in the top 25% of dividend payers in the TW market (6.58%)
Stability and Growth of Payments
Stable Dividend: 6523 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 6523's dividend payments have increased, but the company has only paid a dividend for 6 years.
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (156.7%), 6523's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (169.1%), 6523's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Dr. Yi-Ju Wu, also known as Eric, is a Founder of Dr. Wu Skincare Co., Ltd and serves as its Chairman and has been its Director since February 27, 2003 and serves as its Chief Executive Officer.
Experienced Management: 6523's management team is considered experienced (2.3 years average tenure).
Experienced Board: 6523's board of directors are considered experienced (4.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Dr. Wu Skincare Co., Ltd.'s employee growth, exchange listings and data sources
- Name: Dr. Wu Skincare Co., Ltd.
- Ticker: 6523
- Exchange: TPEX
- Founded: 2003
- Industry: Personal Products
- Sector: Household
- Implied Market Cap: NT$3.676b
- Shares outstanding: 45.05m
- Website: https://www.drwu.com
- Dr. Wu Skincare Co., Ltd.
- No.70, Nanjing East Road
- 13th Floor
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/11 00:00|
|End of Day Share Price||2022/08/10 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.